|
1.Date of the shareholders meeting:2025/05/29
2.Important resolutions (1) Profit distribution/ deficit
compensation:
Ratification of the distribution of 2024 earnings. Cash dividend
to shareholders totals NT$14,736,400. (The cash dividend is
NT$ 0.19 per share)
3.Important resolutions (2) Amendments to the corporate charter:
Approval to amend partial Articles of the Company's Corporate
Charter.
4.Important resolutions (3) Business report and financial statements:
Ratification of the business report and financial statements of 2024.
5.Important resolutions (4) Elections for board of directors and
supervisors:
To elect Directors (including independent directors)
Newly elected Directors：
Representative of China Chemical & Pharmaceutical Co., Ltd./
Wang Hsieh, I-Chen
Representative of China Chemical & Pharmaceutical Co., Ltd./
Wang, Hou-Kai
Representative of Wang Ming-Ning Memorial Foundation. /
Wang, Hou-Jie
Representative of Wang Ming-Ning Memorial Foundation. /
Wu, Shih-Hsuan
Newly elected Independent Directors：
Wang, Kuo-Chiang
Kuan, Arthur
Lee, Ming-Jye
6.Important resolutions (5) Any other proposals:
a. Approval to amend partial Regulations and procedures for
engaging in derivatives trading.
b. Approval to Intend Private Placement for Issuance of Common
Stock Shares or Domestic Convertible Corporate Bonds
(Including Secured or Unsecured Convertible Corporate Bonds).
c. Approval to release non-compete restrictions on newly elected
directors and authorized representatives.
7.Any other matters that need to be specified: None
|
